Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED ...

In order to remove obstacles preventing immediate defibrillation, the medical community and the media worked together to highlight the importance of public access defibrillation. Under increasing ...

In these cases, defibrillation, which delivers an electrical current to the heart via two pads that are placed on the body, can restore a normal heartbeat and increase survival rates — if it's ...

Researchers used an electrophysiological computer model of the heart's electrical circuits to examine the effect of the applied voltage field in multiple fibrillation-defibrillation scenarios.

BOSTON — An investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has exceeded its safety and efficacy expectations in a pivotal clinical trial.

Researchers used data from the Portland Cardiac Arrest Epidemiologic Registry, which comprehensively recorded the placement position of defibrillation pads from July 1, 2019, through June 30, 2023.

The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricle. This new 4.7 French (1.6mm ...

Gentle defibrillation for the heart Date: April 23, 2024 Source: Max Planck Institute for Dynamics and Self-Organization Summary: Using light pulses as a model for electrical defibrillation ...

Medtronic has won Food and Drug Administration approval for the Omniasecure defibrillation lead, the company said Friday. The lead connects to an implantable defibrillator and treats potentially ...

A higher percentage of patients had a good neurologic outcome with DSED but not VC defibrillation compared with standard defibrillation (relative risks [95 percent confidence intervals], 2.21 [1. ...